Your browser doesn't support javascript.
loading
Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer.
Marx, Andreas; Koopmann, Lena; Höflmayer, Doris; Büscheck, Franziska; Hube-Magg, Claudia; Steurer, Stefan; Eichenauer, Till; Clauditz, Till S; Wilczak, Waldemar; Simon, Ronald; Sauter, Guido; Izbicki, Jakob R; Huland, Hartwig; Heinzer, Hans; Graefen, Markus; Haese, Alexander; Schlomm, Thorsten; Bernreuther, Christian; Lebok, Patrick; Bonk, Sarah.
Afiliação
  • Marx A; Institute of Pathology, Klinikum Fürth, Fürth 90766, Germany.
  • Koopmann L; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
  • Höflmayer D; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
  • Büscheck F; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
  • Hube-Magg C; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
  • Steurer S; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
  • Eichenauer T; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
  • Clauditz TS; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
  • Wilczak W; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
  • Simon R; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
  • Sauter G; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
  • Izbicki JR; General, Visceral and Thoracic Surgery Department and Clinic, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
  • Huland H; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
  • Heinzer H; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
  • Graefen M; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
  • Haese A; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
  • Schlomm T; Department of Urology, Charité - Universitätsmedizin Berlin, Berlin 10117, Germany.
  • Bernreuther C; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
  • Lebok P; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
  • Bonk S; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
Cancer Biol Med ; 18(1): 245-255, 2021 02 15.
Article em En | MEDLINE | ID: mdl-33628598
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Anoctaminas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Cancer Biol Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Anoctaminas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Cancer Biol Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha